BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32568485)

  • 21. The Gut Microbiota in Causation, Detection, and Treatment of Cancer.
    Murphy CL; OʼToole PW; Shanahan F
    Am J Gastroenterol; 2019 Jul; 114(7):1036-1042. PubMed ID: 30848738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota and cancer immunotherapy: in search of microbial signals.
    Gharaibeh RZ; Jobin C
    Gut; 2019 Mar; 68(3):385-388. PubMed ID: 30530851
    [No Abstract]   [Full Text] [Related]  

  • 23. Intestinal microbiota: a new force in cancer immunotherapy.
    Dai Z; Zhang J; Wu Q; Fang H; Shi C; Li Z; Lin C; Tang D; Wang D
    Cell Commun Signal; 2020 Jun; 18(1):90. PubMed ID: 32522267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Microbiome; Opportunities and Challenges.
    Nallanchakravarthula S; Amruta N; Ramamurthy C
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):215-229. PubMed ID: 32819239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
    Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
    Osman AEG; Luke JJ
    BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy.
    Wan X; Song M; Wang A; Zhao Y; Wei Z; Lu Y
    Front Immunol; 2021; 12():747914. PubMed ID: 34745119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.
    Wang Y; Ma R; Liu F; Lee SA; Zhang L
    Front Immunol; 2018; 9():374. PubMed ID: 29556232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota-Regulated Outcomes of Human Cancer Immunotherapy via the PD-1/PD-L1 Axis.
    Patel J; Crawford JM
    Biochemistry; 2018 Feb; 57(6):901-903. PubMed ID: 29350031
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation.
    Ceresola ER; Ferrarese R; Preti A; Canducci F
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):7045-7057. PubMed ID: 30402873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fighting cancer with microbes.
    Dolgin E
    Nature; 2020 Jan; 577(7792):S16-S18. PubMed ID: 31996833
    [No Abstract]   [Full Text] [Related]  

  • 32. The intimate relationship between gut microbiota and cancer immunotherapy.
    Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
    Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intestinal microbiom modulates the response to antitumor immunotherapy].
    Olekhnovich EI; Manolov AI; Pavlenko AV; Konanov DN; Fedorov DE; Tikhonova PO; Glushchenko OE; Ilina EN
    Biomed Khim; 2020 Jan; 66(1):54-63. PubMed ID: 32116226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of intestinal microbiota in response to cancer immunotherapy.
    Cong J; Zhang X
    Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2235-2240. PubMed ID: 30209679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbes May Shape Response to Cancer Immunotherapy.
    Hampton T
    JAMA; 2018 Feb; 319(5):430-431. PubMed ID: 29411013
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of the intestinal microbiota in therapeutic responses against cancer.
    Goubet AG; Daillère R; Routy B; Derosa L; M Roberti P; Zitvogel L
    C R Biol; 2018; 341(5):284-289. PubMed ID: 29631891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiota Manipulated to Enhance Immunity.
    Cancer Discov; 2019 Jul; 9(7):822. PubMed ID: 31072874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POSTOPERATIVE CHANGES IN INTESTINAL MICROBIOTA AND USE OF PROBIOTICS IN ROUX-EN-Y GASTRIC BYPASS AND SLEEVE VERTICAL GASTRECTOMY: AN INTEGRATIVE REVIEW.
    Wagner NRF; Zaparolli MR; Cruz MRR; Schieferdecker MEM; Campos ACL
    Arq Bras Cir Dig; 2018 Dec; 31(4):e1400. PubMed ID: 30539975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MICROBIOME. Microbes aid cancer drugs.
    Leslie M
    Science; 2015 Nov; 350(6261):614-5. PubMed ID: 26542545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.